Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Large Blend · Janus Henderson

Janus Henderson Venture Fund Class N (JVTNX)

Ticker JVTNX · · Holdings as of Jun 30, 2026

Expense ratio
0.67%$67/yr per $10k
Net assets
$3.6Ball share classes
Holdings
175

Bottom line

Is JVTNX a good fund? The bottom line

JVTNX is the Class N share class of Janus Henderson Venture Fund, a managed large blend mutual fund from Janus Henderson.

Annual fees run 0.67% — about $67 a year on every $10,000 invested, cheaper than 64% of large blend funds we track.

With $3.6 billion in net assets and 175 holdings, its largest position is Glaukos Corp. (2.6%) and the top 10 make up 20.1% of the portfolio.

What stands out

  • No front-end sales load

Updated Nov 19, 2026

What JVTNX invests in

Janus Henderson Venture Fund seeks capital appreciation.

The Fund pursues its investment objective by investing at least 50% of its net assets in small-sized companies. The Fund may also invest in larger companies with strong growth potential. Small-sized companies are defined by portfolio management as those companies whose market capitalization falls within the 12-month capitalization range of the Russell 2000 Growth Index at the time of purchase. Market capitalization is a commonly used measure of the size and value of a company. The market capitalizations within the index will vary, but as of September 30, 2025, they ranged from approximately $4 million to $21.31 billion. The Fund may invest in shares of companies through initial public offerings and secondary offerings. Portfolio management applies a bottom-up approach in choosing investments. In other words, portfolio management looks at companies one at a time to determine if a…

From the fund's prospectus (filed Jan 28, 2026).

What JVTNX costs

On a $10,000 investment, JVTNX's 0.67% expense ratio costs about $67 a year. The prospectus estimates $835 in total costs over 10 years (assuming 5% annual returns). The median large blend fund charges 0.83%.

See the full JVTNX fee table →

JVTNX top 10 holdings

#Holding% of fund
1Glaukos Corp.2.59%
2Ligand Pharmaceuticals, Inc.2.41%
3Perimeter Solutions, Inc.2.19%
4SPX Technologies, Inc.2.12%
5Revolution Medicines, Inc.1.99%
6Tower Semiconductor Ltd.1.89%
7CECO Environmental Corp.1.87%
8Legence Corp.1.73%
9Casey's General Stores, Inc.1.70%
10Janus Henderson Cash Liquidity Fund LLC1.64%

Source: SEC Form N-PORT, period ended Jun 30, 2026

The top 10 make up 20.1% of the fund. See all top 25 holdings and asset mix →

Alternatives to JVTNX

More funds like JVTNX →

JVTNX FAQ

What is the expense ratio of JVTNX?
JVTNX's expense ratio is 0.67%, which works out to about $67 a year for every $10,000 invested. The prospectus estimates total costs of $835 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is JVTNX a good investment?
It depends on your goals, but the data points to: no front-end sales load. This is general information, not personalized advice.
What does JVTNX hold?
JVTNX's largest holdings are Glaukos Corp. (2.6%), Ligand Pharmaceuticals, Inc. (2.4%), Perimeter Solutions, Inc. (2.2%), SPX Technologies, Inc. (2.1%), Revolution Medicines, Inc. (2.0%). It holds 175 positions in total as of Jun 30, 2026 (SEC Form N-PORT).
Does JVTNX have a sales load?
No. JVTNX has no front-end sales charge.
Who manages JVTNX?
JVTNX is offered by Janus Henderson through Janus Investment Fund.